Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT)
conducted a revision of the 2009 guidelines by updating the evidence and …

Abstract Background Prefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated
daily over 4–6 weeks (20–30 sessions) is US Food and Drug Administration (FDA) approved …

Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

Objective: New antidepressant treatments are needed that are effective, rapid acting, safe,
and tolerable. Intermittent theta-burst stimulation (iTBS) is a noninvasive brain stimulation …

Transcranial magnetic stimulation (TMS) is used to treat multiple psychiatric and
neurological conditions by manipulating activity in particular brain networks and circuits, but …

Objective: To provide expert recommendations for the safe and effective application of
repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive …

Background The optimal target in the dorsolateral prefrontal cortex for treating depression
with repetitive transcranial magnetic stimulation (rTMS) remains unknown. Better efficacy …

The functional integration of external and internal signals forms the basis of information
processing and is essential for higher cognitive functions. This occurs in finely tuned cortical …

Transcranial focused ultrasound (US) has been demonstrated to stimulate neurons in
animals and humans, but the mechanism of this effect is unknown. It has been hypothesized …

The brain has the innate ability to undergo neuronal plasticity, which refers to changes in its
structure and functions in response to continued changes in the environment. Although …